Diversified Healthcare Trust Announces 2023 Dividend Allocation

16 Jan 2024
www.businesswire.com
NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced that the characterization of dividends for 2023 income tax reporting purposes is as follows:
Common Shares
Dividend Allocation Per Share
Section
Total
Unrecaptured
Declaration
Record
Paid/Payable
Dividends
Ordinary
199A
Qualified
Capital
Section 1250
Return of
Dates
Dates
Dates
Per Share
Income
Dividend(1)
Dividend(2)
Gain
Gain(3)
Capital
01/12/23
01/23/23
02/16/23
$0.0100
$ 0.0000
$ 0.0000
$ 0.0000
$ 0.0000
$ 0.0000
$0.0100
04/13/23
04/24/23
05/18/23
$0.0100
$ 0.0000
$ 0.0000
$ 0.0000
$ 0.0000
$ 0.0000
$0.0100
07/13/23
07/24/23
08/17/23
$0.0100
$ 0.0000
$ 0.0000
$ 0.0000
$ 0.0000
$ 0.0000
$0.0100
10/12/23
10/23/23
11/16/23
$0.0100
$ 0.0000
$ 0.0000
$ 0.0000
$ 0.0000
$ 0.0000
$0.0100
TOTALS:
$0.0400
$0.0400
$0.0000
$0.0000
$0.0000
$0.0000
$0.0400
(1)
Section 199A Dividends are a subset of, and included in, the Ordinary Income amount.
(2)
Qualified Dividends are a subset of, and included in, the Ordinary Income amount.
(3)
Unrecaptured Section 1250 Gain is a subset of, and included in, the Total Capital Gain amount.
DHC’s common share CUSIP number is 25525P107. This information represents final income allocations.
Shareholders should look to IRS Form 1099-DIV for their tax reporting. This press release is not intended to replace the Form 1099-DIV. For additional information regarding the effect on the tax basis of DHC shares, please see Form(s) 8937 published on the DHC website: https://www.dhcreit.com/investors/stock-information/distributions/default.aspx
Diversified Healthcare Trust is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of September 30, 2023, DHC’s approximately $7.2 billion portfolio included 376 properties in 36 states and Washington, D.C., occupied by approximately 500 tenants, and totaling approximately nine million square feet of life science and medical office properties and more than 27,000 senior living units. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with approximately $36 billion in assets under management as of September 30, 2023 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. To learn more about DHC, visit www.dhcreit.com.
A Maryland Real Estate Investment Trust with transferable shares of beneficial interest listed on the Nasdaq.
No shareholder, Trustee or officer is personally liable for any act or obligation of the Trust.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.